HEADER TOXIN/CELL CYCLE 05-JUN-02 1GZS TITLE CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE GEF DOMAIN OF THE TITLE 2 SALMONELLA TYPHIMURIUM SOPE TOXIN AND HUMAN CDC42 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GTP-BINDING PROTEIN; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: RESIDUES 1-178; COMPND 5 SYNONYM: PLACENTAL ISOFORM, CDC42 G25K; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: SOPE; COMPND 9 CHAIN: B, D; COMPND 10 FRAGMENT: GUANINE NUCTLEOTIDE EXCHANGE FACTOR (GEF-DOMAIN), RESIDUES COMPND 11 78-240; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PGEX-2T; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: SALMONELLA TYPHIMURIUM; SOURCE 10 ORGANISM_TAXID: 602; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 13 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 14 EXPRESSION_SYSTEM_PLASMID: PGEX-2T KEYWDS TOXIN/CELL CYCLE, COMPLEX (TOXIN-CELL CYCLE PROTEIN), SOPE, CDC42, KEYWDS 2 SALMONELLA TYPHIMURIUM, GEF, TOXIN, GTP- BINDING, LIPOPROTEIN, KEYWDS 3 PRENYLATION, TOXIN-CELL CYCLE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.BUCHWALD,A.FRIEBEL,J.E.GALAN,W.D.HARDT,A.WITTINGHOFER,K.SCHEFFZEK REVDAT 4 08-MAY-24 1GZS 1 REMARK REVDAT 3 24-FEB-09 1GZS 1 VERSN REVDAT 2 16-JAN-03 1GZS 1 DBREF REVDAT 1 12-SEP-02 1GZS 0 JRNL AUTH G.BUCHWALD,A.FRIEBEL,J.E.GALAN,W.D.HARDT,A.WITTINGHOFER, JRNL AUTH 2 K.SCHEFFZEK JRNL TITL STRUCTURAL BASIS FOR THE REVERSIBLE ACTIVATION OF A RHO JRNL TITL 2 PROTEIN BY THE BACTERIAL TOXIN SOPE JRNL REF EMBO J. V. 21 3286 2002 JRNL REFN ISSN 0261-4189 JRNL PMID 12093730 JRNL DOI 10.1093/EMBOJ/CDF329 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.86 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 5242854.300 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 40297 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4012 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5943 REMARK 3 BIN R VALUE (WORKING SET) : 0.2300 REMARK 3 BIN FREE R VALUE : 0.2740 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 659 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5308 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.34000 REMARK 3 B22 (A**2) : -1.34000 REMARK 3 B33 (A**2) : 2.69000 REMARK 3 B12 (A**2) : 2.10000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.16 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.25 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.890 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 37.16 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GZS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-JUN-02. REMARK 100 THE DEPOSITION ID IS D_1290009921. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.60 REMARK 200 NUMBER OF CRYSTALS USED : 3 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40507 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 8.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.11200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.32800 REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIRAS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.9 M (NH4)2SO4, 0.1 M SODIUM CITRATE REMARK 280 PH 5.6, 2% PEG400, 0.05 M BETAINE, PH 5.60 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.83633 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 133.67267 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 133.67267 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 66.83633 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 GLY C -2 REMARK 465 SER C -1 REMARK 465 GLY D 76 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 27 140.14 179.28 REMARK 500 PRO A 29 87.83 -69.02 REMARK 500 GLU A 31 -45.51 71.42 REMARK 500 LYS A 96 -62.74 -132.78 REMARK 500 LYS A 153 168.31 178.21 REMARK 500 SER B 77 -92.58 -66.57 REMARK 500 LEU B 78 82.84 38.46 REMARK 500 ASP B 95 73.73 39.22 REMARK 500 PRO C 29 85.93 -59.04 REMARK 500 SER C 30 -104.37 -30.30 REMARK 500 TYR C 32 123.79 -170.95 REMARK 500 SER C 86 88.30 -151.06 REMARK 500 LYS C 96 -64.34 -121.48 REMARK 500 LYS C 131 6.90 -65.40 REMARK 500 THR D 79 -16.27 52.83 REMARK 500 THR D 239 79.62 -159.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 406 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A4R RELATED DB: PDB REMARK 900 G12V MUTANT OF HUMAN PLACENTAL CDC42 GTPASE IN THE GDP FORM REMARK 900 RELATED ID: 1AJE RELATED DB: PDB REMARK 900 CDC42 FROM HUMAN, NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1AN0 RELATED DB: PDB REMARK 900 CDC42HS-GDP COMPLEX REMARK 900 RELATED ID: 1CEE RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF CDC42 IN COMPLEX WITH THE GTPASE BINDING REMARK 900 DOMAIN OF WASP REMARK 900 RELATED ID: 1CF4 RELATED DB: PDB REMARK 900 CDC42/ACK GTPASE-BINDING DOMAIN COMPLEX REMARK 900 RELATED ID: 1DOA RELATED DB: PDB REMARK 900 STRUCTURE OF THE RHO FAMILY GTP-BINDING PROTEIN CDC42 INCOMPLEX REMARK 900 WITH THE MULTIFUNCTIONAL REGULATOR RHOGDI REMARK 900 RELATED ID: 1E0A RELATED DB: PDB REMARK 900 CDC42 COMPLEXED WITH THE GTPASE BINDING DOMAIN OF P21 ACTIVATED REMARK 900 KINASE REMARK 900 RELATED ID: 1EES RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF CDC42HS COMPLEXED WITH A PEPTIDE DERIVED FROM REMARK 900 P-21 ACTIVATED KINASE, NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1GRN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CDC42/CDC42GAP/ALF3 COMPLEX. REMARK 900 RELATED ID: 1KI1 RELATED DB: PDB REMARK 900 GUANINE NUCLEOTIDE EXCHANGE REGION OF INTERSECTIN INCOMPLEX WITH REMARK 900 CDC42 REMARK 900 RELATED ID: 1KZ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE DH/PH FRAGMENT OF MURINE DBS INCOMPLEX REMARK 900 WITH THE PLACENTAL ISOFORM OF HUMAN CDC42 REMARK 900 RELATED ID: 1KZG RELATED DB: PDB REMARK 900 DBSCDC42(Y889F) REMARK 900 RELATED ID: 2NGR RELATED DB: PDB REMARK 900 TRANSITION STATE COMPLEX FOR GTP HYDROLYSIS BY CDC42: COMPARISONS REMARK 900 OF THE HIGH RESOLUTION STRUCTURES FOR CDC42 BOUND TO THE ACTIVE AND REMARK 900 CATALYTICALLY COMPROMISED FORMS OF THE CDC42-GAP. DBREF 1GZS A -2 -1 PDB 1GZS 1GZS -2 -1 DBREF 1GZS A 1 178 UNP P25763 G25P_HUMAN 1 178 DBREF 1GZS B 76 77 PDB 1GZS 1GZS 76 77 DBREF 1GZS B 78 240 UNP O52623 O52623 78 240 DBREF 1GZS C -2 -1 PDB 1GZS 1GZS -2 -1 DBREF 1GZS C 1 178 UNP P25763 G25P_HUMAN 1 178 DBREF 1GZS D 76 77 PDB 1GZS 1GZS 76 77 DBREF 1GZS D 78 240 UNP O52623 O52623 78 240 SEQRES 1 A 180 GLY SER MET GLN THR ILE LYS CYS VAL VAL VAL GLY ASP SEQRES 2 A 180 GLY ALA VAL GLY LYS THR CYS LEU LEU ILE SER TYR THR SEQRES 3 A 180 THR ASN LYS PHE PRO SER GLU TYR VAL PRO THR VAL PHE SEQRES 4 A 180 ASP ASN TYR ALA VAL THR VAL MET ILE GLY GLY GLU PRO SEQRES 5 A 180 TYR THR LEU GLY LEU PHE ASP THR ALA GLY GLN GLU ASP SEQRES 6 A 180 TYR ASP ARG LEU ARG PRO LEU SER TYR PRO GLN THR ASP SEQRES 7 A 180 VAL PHE LEU VAL CYS PHE SER VAL VAL SER PRO SER SER SEQRES 8 A 180 PHE GLU ASN VAL LYS GLU LYS TRP VAL PRO GLU ILE THR SEQRES 9 A 180 HIS HIS CYS PRO LYS THR PRO PHE LEU LEU VAL GLY THR SEQRES 10 A 180 GLN ILE ASP LEU ARG ASP ASP PRO SER THR ILE GLU LYS SEQRES 11 A 180 LEU ALA LYS ASN LYS GLN LYS PRO ILE THR PRO GLU THR SEQRES 12 A 180 ALA GLU LYS LEU ALA ARG ASP LEU LYS ALA VAL LYS TYR SEQRES 13 A 180 VAL GLU CYS SER ALA LEU THR GLN LYS GLY LEU LYS ASN SEQRES 14 A 180 VAL PHE ASP GLU ALA ILE LEU ALA ALA LEU GLU SEQRES 1 B 165 GLY SER LEU THR ASN LYS VAL VAL LYS ASP PHE MET LEU SEQRES 2 B 165 GLN THR LEU ASN ASP ILE ASP ILE ARG GLY SER ALA SER SEQRES 3 B 165 LYS ASP PRO ALA TYR ALA SER GLN THR ARG GLU ALA ILE SEQRES 4 B 165 LEU SER ALA VAL TYR SER LYS ASN LYS ASP GLN CYS CYS SEQRES 5 B 165 ASN LEU LEU ILE SER LYS GLY ILE ASN ILE ALA PRO PHE SEQRES 6 B 165 LEU GLN GLU ILE GLY GLU ALA ALA LYS ASN ALA GLY LEU SEQRES 7 B 165 PRO GLY THR THR LYS ASN ASP VAL PHE THR PRO SER GLY SEQRES 8 B 165 ALA GLY ALA ASN PRO PHE ILE THR PRO LEU ILE SER SER SEQRES 9 B 165 ALA ASN SER LYS TYR PRO ARG MET PHE ILE ASN GLN HIS SEQRES 10 B 165 GLN GLN ALA SER PHE LYS ILE TYR ALA GLU LYS ILE ILE SEQRES 11 B 165 MET THR GLU VAL ALA PRO LEU PHE ASN GLU CYS ALA MET SEQRES 12 B 165 PRO THR PRO GLN GLN PHE GLN LEU ILE LEU GLU ASN ILE SEQRES 13 B 165 ALA ASN LYS TYR ILE GLN ASN THR PRO SEQRES 1 C 180 GLY SER MET GLN THR ILE LYS CYS VAL VAL VAL GLY ASP SEQRES 2 C 180 GLY ALA VAL GLY LYS THR CYS LEU LEU ILE SER TYR THR SEQRES 3 C 180 THR ASN LYS PHE PRO SER GLU TYR VAL PRO THR VAL PHE SEQRES 4 C 180 ASP ASN TYR ALA VAL THR VAL MET ILE GLY GLY GLU PRO SEQRES 5 C 180 TYR THR LEU GLY LEU PHE ASP THR ALA GLY GLN GLU ASP SEQRES 6 C 180 TYR ASP ARG LEU ARG PRO LEU SER TYR PRO GLN THR ASP SEQRES 7 C 180 VAL PHE LEU VAL CYS PHE SER VAL VAL SER PRO SER SER SEQRES 8 C 180 PHE GLU ASN VAL LYS GLU LYS TRP VAL PRO GLU ILE THR SEQRES 9 C 180 HIS HIS CYS PRO LYS THR PRO PHE LEU LEU VAL GLY THR SEQRES 10 C 180 GLN ILE ASP LEU ARG ASP ASP PRO SER THR ILE GLU LYS SEQRES 11 C 180 LEU ALA LYS ASN LYS GLN LYS PRO ILE THR PRO GLU THR SEQRES 12 C 180 ALA GLU LYS LEU ALA ARG ASP LEU LYS ALA VAL LYS TYR SEQRES 13 C 180 VAL GLU CYS SER ALA LEU THR GLN LYS GLY LEU LYS ASN SEQRES 14 C 180 VAL PHE ASP GLU ALA ILE LEU ALA ALA LEU GLU SEQRES 1 D 165 GLY SER LEU THR ASN LYS VAL VAL LYS ASP PHE MET LEU SEQRES 2 D 165 GLN THR LEU ASN ASP ILE ASP ILE ARG GLY SER ALA SER SEQRES 3 D 165 LYS ASP PRO ALA TYR ALA SER GLN THR ARG GLU ALA ILE SEQRES 4 D 165 LEU SER ALA VAL TYR SER LYS ASN LYS ASP GLN CYS CYS SEQRES 5 D 165 ASN LEU LEU ILE SER LYS GLY ILE ASN ILE ALA PRO PHE SEQRES 6 D 165 LEU GLN GLU ILE GLY GLU ALA ALA LYS ASN ALA GLY LEU SEQRES 7 D 165 PRO GLY THR THR LYS ASN ASP VAL PHE THR PRO SER GLY SEQRES 8 D 165 ALA GLY ALA ASN PRO PHE ILE THR PRO LEU ILE SER SER SEQRES 9 D 165 ALA ASN SER LYS TYR PRO ARG MET PHE ILE ASN GLN HIS SEQRES 10 D 165 GLN GLN ALA SER PHE LYS ILE TYR ALA GLU LYS ILE ILE SEQRES 11 D 165 MET THR GLU VAL ALA PRO LEU PHE ASN GLU CYS ALA MET SEQRES 12 D 165 PRO THR PRO GLN GLN PHE GLN LEU ILE LEU GLU ASN ILE SEQRES 13 D 165 ALA ASN LYS TYR ILE GLN ASN THR PRO HET SO4 A 401 5 HET SO4 A 402 5 HET SO4 A 403 5 HET SO4 A 405 5 HET SO4 C 404 5 HET SO4 C 406 5 HETNAM SO4 SULFATE ION FORMUL 5 SO4 6(O4 S 2-) FORMUL 11 HOH *160(H2 O) HELIX 1 1 GLY A 15 ASN A 26 1 12 HELIX 2 2 LEU A 67 TYR A 72 5 6 HELIX 3 3 SER A 86 LYS A 96 1 11 HELIX 4 4 LYS A 96 CYS A 105 1 10 HELIX 5 5 GLN A 116 ARG A 120 5 5 HELIX 6 6 ASP A 122 LYS A 131 1 10 HELIX 7 7 THR A 138 LEU A 149 1 12 HELIX 8 8 GLY A 164 GLU A 178 1 15 HELIX 9 9 THR B 79 ASP B 95 1 17 HELIX 10 10 ASP B 95 ASP B 103 1 9 HELIX 11 11 ASP B 103 LYS B 133 1 31 HELIX 12 12 ILE B 137 ALA B 151 1 15 HELIX 13 13 PHE B 172 TYR B 184 1 13 HELIX 14 14 PRO B 185 ILE B 189 5 5 HELIX 15 15 ASN B 190 ALA B 210 1 21 HELIX 16 16 PRO B 211 ASN B 214 5 4 HELIX 17 17 THR B 220 GLN B 237 1 18 HELIX 18 18 GLY C 15 ASN C 26 1 12 HELIX 19 19 LEU C 67 TYR C 72 5 6 HELIX 20 20 SER C 86 LYS C 96 1 11 HELIX 21 21 LYS C 96 CYS C 105 1 10 HELIX 22 22 GLN C 116 ARG C 120 5 5 HELIX 23 23 ASP C 122 LYS C 131 1 10 HELIX 24 24 THR C 138 LEU C 149 1 12 HELIX 25 25 GLY C 164 LEU C 177 1 14 HELIX 26 26 THR D 79 ASP D 95 1 17 HELIX 27 27 ASP D 95 ASP D 103 1 9 HELIX 28 28 ASP D 103 GLY D 134 1 32 HELIX 29 29 ILE D 137 ALA D 151 1 15 HELIX 30 30 PHE D 172 TYR D 184 1 13 HELIX 31 31 PRO D 185 ILE D 189 5 5 HELIX 32 32 ASN D 190 ALA D 210 1 21 HELIX 33 33 PRO D 211 ASN D 214 5 4 HELIX 34 34 THR D 220 GLN D 237 1 18 SHEET 1 AA 6 ALA A 41 ILE A 46 0 SHEET 2 AA 6 GLU A 49 PHE A 56 -1 O GLU A 49 N ILE A 46 SHEET 3 AA 6 GLN A 2 GLY A 10 1 O GLN A 2 N THR A 52 SHEET 4 AA 6 VAL A 77 SER A 83 1 O VAL A 77 N VAL A 7 SHEET 5 AA 6 PHE A 110 THR A 115 1 O LEU A 111 N VAL A 80 SHEET 6 AA 6 TYR A 154 GLU A 156 1 O VAL A 155 N GLY A 114 SHEET 1 BA 2 GLY B 155 LYS B 158 0 SHEET 2 BA 2 VAL B 161 PRO B 164 -1 O VAL B 161 N LYS B 158 SHEET 1 CA 6 ALA C 41 ILE C 46 0 SHEET 2 CA 6 GLU C 49 PHE C 56 -1 O GLU C 49 N ILE C 46 SHEET 3 CA 6 GLN C 2 VAL C 9 1 O GLN C 2 N THR C 52 SHEET 4 CA 6 VAL C 77 SER C 83 1 O VAL C 77 N VAL C 7 SHEET 5 CA 6 PHE C 110 THR C 115 1 O LEU C 111 N VAL C 80 SHEET 6 CA 6 TYR C 154 GLU C 156 1 O VAL C 155 N GLY C 114 SHEET 1 DA 2 GLY D 155 LYS D 158 0 SHEET 2 DA 2 VAL D 161 PRO D 164 -1 O VAL D 161 N LYS D 158 SITE 1 AC1 5 GLU A 62 ASP A 63 ARG A 68 LYS A 96 SITE 2 AC1 5 ARG D 186 SITE 1 AC2 4 HIS A 104 CYS A 105 LYS A 107 THR A 108 SITE 1 AC3 9 ASP A 11 GLY A 12 ALA A 13 VAL A 14 SITE 2 AC3 9 GLY A 15 LYS A 16 THR A 17 ALA A 59 SITE 3 AC3 9 HOH A2038 SITE 1 AC4 3 SER A 86 PRO A 87 SER A 88 SITE 1 AC5 8 ASP C 11 GLY C 12 ALA C 13 VAL C 14 SITE 2 AC5 8 GLY C 15 LYS C 16 THR C 17 ALA C 59 SITE 1 AC6 5 HIS C 104 CYS C 105 PRO C 106 LYS C 107 SITE 2 AC6 5 THR C 108 CRYST1 87.545 87.545 200.509 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011423 0.006595 0.000000 0.00000 SCALE2 0.000000 0.013190 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004987 0.00000 MTRIX1 1 0.367580 -0.263080 0.892000 -96.45638 1 MTRIX2 1 0.168370 -0.924480 -0.342040 136.63788 1 MTRIX3 1 0.914620 0.275910 -0.295520 56.71050 1